Copper peptides: what the evidence shows

Copper peptide can describe different ingredients and routes. A skin serum, a compounded preparation and an injection answer different questions. The published evidence needs to match the finished product and its intended use.

Retail products show why ingredient identity matters: The Ordinary and Biossance list Copper Tripeptide-1, NIOD describes GHK-Cu, and Medik8 lists a different copper peptide. These are product-label facts, not comparable clinical outcome data. Their advertised percentages cannot by themselves establish relative effectiveness.

Mochi lists a scalp serum and a face cream as cosmetics in its longevity catalog. The public cards omit a full ingredient list and package size. The scalp serum displays a percentage without its measurement basis; the face cream displays a mass without a denominator. These entries are useful to know about, but cannot be compared per volume with retail serums or identified as GHK-Cu yet.

By Designing Longevity · Sources checked October 15, 2026 · How we compare

Compare the options

Appearance

Finished topical cosmetic

Assess the exact formula and its appearance claims. A copper ingredient does not prove a collagen-building or hair-regrowth outcome.

Evidence in people: The cited topical GHK-Cu trial studied laser-resurfaced skin, not every serum or scalp product.
Commitment: Depends on package size and purchase terms.
Before you pay: Check full ingredient list, size, label and current product terms.

The question to answer: What is the named copper ingredient on the package?

Read the full explanation

Separate drug question

Compounded non-injectable GHK-Cu

A nominated bulk ingredient under evaluation is not an approved finished product.

Evidence in people: FDA lists non-injectable GHK-Cu nomination under evaluation.
Commitment: Depends on the clinical service and preparation.
Before you pay: Confirm route, prescription context, pharmacy and specific claims.

The question to answer: What exact preparation, indication and regulatory basis apply?

Research context

Injectable GHK-Cu

The topical cosmetic evidence cannot establish an injectable benefit or safety profile.

Evidence in people: The topical trial and non-injectable nomination do not establish an injectable use.
Commitment: No shopping comparison here.
Before you pay: Read the route-specific research and FDA compounding status.

The question to answer: Is there human evidence for this route and outcome?

Read the full explanation

What makes a product comparison fair?

A named ingredient is the first check. Two similarly named serums can use different copper peptides, and a cosmetic scalp product has a different purpose from a facial serum. Check the current package label because online ingredient lists can change.

The retail product comparison linked below addresses disclosed size, stock and purchase terms. These details support a practical shopping comparison but do not rank efficacy. Mochi’s catalog entries need their full ingredient declarations and package details before a like-for-like placement.

What does the GHK-Cu research establish?

A small randomized trial studied a topical copper tripeptide complex after CO2 laser resurfacing. That setting differs from routine cosmetic use, and it cannot establish hair regrowth, collagen-building performance or outcomes for the specific products here. Ingredient research is a reason to ask better questions, not a product verdict.

The FDA distinguishes cosmetic appearance claims from claims about changing skin structure or treating a condition. It also handles compounding status separately from finished cosmetic products. FDA nomination status for non-injectable GHK-Cu is under evaluation; it is not authorization for an injectable recommendation.

Why Mochi catalog entries sit apart

The Mochi scalp serum and face cream are listed as cosmetics, but their public cards do not show full ingredient declarations or package sizes. The serum’s displayed percentage and cream’s displayed mass lack the same basis, so comparing those numbers would mislead. Confirm the exact product and checkout terms before treating either as equivalent to a retail serum.

Frequently asked questions

Which copper serum works best?

These public pages do not provide comparable clinical trials of the finished products. Compare the disclosed ingredient, size, formula fit and purchase terms without assigning an efficacy winner.

Is a displayed percentage a fair comparison?

Only when it refers to the same ingredient and measurement basis. A mass display and a percentage are not numerically interchangeable.

Can I infer hair regrowth from the Mochi serum name?

No. Mochi calls it a cosmetic, and its public listing does not establish that outcome.

How we compare

We start with a reader’s decision, then separate published facts from our judgment. Government and professional sources support health explanations; a brand’s page supports what it lists, charges or promises. We have not tested these products or assessed individual treatment suitability.

Our cosmetic comparison covers four selected retail facial serums and two separately labeled Mochi catalog entries. We chose products with an identifiable copper ingredient or an explicit copper-product listing. It is a researched shortlist, not the whole U.S. market. Feature picks concern disclosed ingredients, bottle size or purchase terms; they do not score results or medical quality.

Prices and stock reflect the dated check, with missing facts shown explicitly. We withhold expired quotations and product-shopping links that lack the required label review. Monthly editions advance after a completed source check. Product source links use the brands’ public URLs. This content is not medically reviewed.

Linked guides keep their own source dates and limitations.

Our editorial process Report a correction How we assess evidence Explore another health topic